Trial Profile
To evaluate the virologic activity of SCH 532706 coadministered with ritonavir in CCR5-tropic HIV-infected individuals.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs SCH 532706 (Primary) ; Ritonavir
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 30 Jun 2016 New trial record